Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Ns5a'

Ns5a published presentations and documents on DocSlides.

HIV Pipeline Cabotegravir-LA
HIV Pipeline Cabotegravir-LA
by liane-varnes
(GSK-744; CAB). For . PrEP. INI. ViiV. Topical mi...
HIV Pipeline Doravirine 2
HIV Pipeline Doravirine 2
by giovanna-bartolotta
(MK-1439; DOR). . NNRTI. Merck. Filed with USFDA...
Newest Drugs for Hepatitis C
Newest Drugs for Hepatitis C
by tawny-fly
Matthew Luu, Yuan Fang (Pearl) Cai, Shiming Sun, ...
Virological characterization of patients with CHC and failure to a
Virological characterization of patients with CHC and failure to a
by isabella2
glecaprevir. /. pibrentasvir. or . voxilaprevir. ...
The Role of Diagnostics in the Management of HCV and HIV
The Role of Diagnostics in the Management of HCV and HIV
by zoe
Presented by: Thomas E. Burgess, PhD, DABCC, FAACC...
The Paradox of Highly Effective
The Paradox of Highly Effective
by Kingslayer
Sofosbuvir. . Combo Therapy . Despite . Slow . He...
NS5A and polymerase inhibitors
NS5A and polymerase inhibitors
by LoveBug
Mark Sulkowski, MD. Professor of Medicine. Johns H...
Not randomised Open-label
Not randomised Open-label
by phoebe-click
18-70 years. Naïve . or failure to. PEG-IFN RB...
SOF/VEL/VOX
SOF/VEL/VOX
by pamella-moone
400/100/100 mg QD. N = 263. N = 152. W12. Placebo...
Forns
Forns
by ellena-manuel
X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...
SOF/VEL + RBV
SOF/VEL + RBV
by celsa-spraggs
N = 69. >. 18 years. Failure to SOF/VEL . or ...
No randomisation
No randomisation
by pamella-moone
Open-label. 18-70 years. HCV genotype 1. Naïve o...
Direct Acting Antivirals: What are they? What is their pl
Direct Acting Antivirals: What are they? What is their pl
by tawny-fly
Mark Sulkowski, MD. Associate Professor of Medici...